Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Antimicrobial Resistance

Beyond the Breakpoint

Editor(s): Weber J.T. (Stockholm) 

Status: available   
Publication year: 2010
Buy this book
Digital Version: CHF 189.00, EUR 177.00, USD 222.00
Print Version: CHF 189.00, EUR 177.00, USD 222.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.

This book belongs to
Issues in Infectious Diseases , Vol. 6
Editor(s): Mahy B.W.J. (Bury St. Edmunds) 
X + 174 p., 4 fig., 18 tab., hard cover, 2010
Status: available   
ISSN: 1660-1890
e-ISSN: 1662-3819

Read the reviews


'The strength of this book is the wide scope of its coverage of antimicrobial drug resistance. Most chapters are well written in a succinct style and format easily accessible to the general reader. The text has supportive references from primary sources, and contains a good index. This book is a valuable resource for those beginning their careers or who are looking for a research focus, or for anyone already an expert in an aspect of antimicrobial resistance who is seeking a broader perspective.'
David J. Pombo
(Emerging Infectious Diseases®, Vol.16, No. 9, Sept. 2010)

'This collection comprises 10 individual reviews that have been written by experts in their field. [...] There are two excellent reviews by Belongia et al and Rezai et al that examine the effectiveness of controlled antibiotic prescribing practices as a means of addressing the "human factor" associated with the development of antimicrobial resistance. A focus on optimal antimicrobial selection and dosing, duration of therapy and patient acceptance of non-antimicrobial treatments plans are also proposed as part of a succesful multi-faceted approach to changing the behaviour of patients and clinicians in the outpatient setting.'
Narelle George, Supervising Scientist - Central Laboratory Pathology Queensland, Herston
(Australian Journal of Medical Science, Vol. 31, No. 4, Nov. 2010)

'The consequences of infections due to these antibiotic-resistant microbes even led to reservations of informed patients to enter hospitals, since it is known by the informed public that medical facilities are often sources for the acquisition of infections due to multi-resistant pathogens. A fatal world-wide condition which is perfectly specified within this book also considering the full scale of costs of antimicrobial resistance to society, both in human and economic terms.[...]
An excellent book on an important topic for a reasonable prize.'
Axel Schmidt, Witten/Herdecke
(Arzneimittelforschung / Drug Research, Vol. 60, No.9, 2010)

When the drugs don’t work: halting the rise of antimicrobial-resistant pathogens
Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.
Each chapter provides essential background and examines the evidence for an important aspect of prevention and control, treatment strategy or policy decision. Prevention and control strategies are analyzed for inappropriate antimicrobial use, fluoroquinolone-resistant organisms, health-care associated infections and parasitic diseases. Furthermore, treatment strategies for changing resistance patterns are explored for community-acquired pneumonia during an influenza pandemic and infections with community-associated MRSA, extended-spectrum beta-lactamase producing organisms and fungi. Data for policy making are presented in articles that detail the costs of antimicrobial-resistant infections in healthcare settings and the threat of resistance with the introduction of antiretroviral therapy for large populations in the developing world. These reviews show where interventions, surveillance and research will be most useful in the future. Antimicrobial Resistance is an invaluable contribution for infectious disease physicians and public health officials who are interested in the prevention of antimicrobial-resistant infections.